Skin cancer risk following radioactive iodine therapy

Radioactive iodine therapy could increase the risk of skin cancer in patients with thyroid cancer.

In a study published in JAMA Network Open, investigators examined the outcomes of 174,916 patients with primary thyroid cancer who received or did not receive treatment with radioactive iodine therapy between 2000 and 2019.

The investigators found that those who underwent treatment were more likely to develop melanoma and nonkeratinocyte skin cancers. The patients who weren’t treated with radioactive iodine therapy had no increased risk of skin cancer.

The investigators proposed that patients with thyroid cancer undergoing radioactive iodine therapy should receive routine skin cancer surveillance.

Read more: JAMA Network Open

The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.